Teneliximab Antibody
Teneliximab (BMS 224819) is a chimeric anti-CD40 monoclonal antibody that acts as a partial agonist, blocking CD40-CD40L interactions and depleting peripheral B-cells. It is a research tool for studying autoimmune diseases like rheumatoid arthritis and mechanisms of transplant rejection in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
CD40, Chi220, Anti-Human CD40 Recombinant Antibody, BMS 224819, BMS224819, BMS-224819, Teneliximab
Target
TNF
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
4.27 mg/mL
Purity
>95.0% (May vary between batches)
Molecular Weight
146.06 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6426807-01 0.1 mL
MLH1 (Human Mul L Homologue, Familial Nonpolyposis Colin Cancer Type 2, COCA2, Colon Cancer Type 2, COCA2, FCC2, HNPCC, HNPCC2, MGC5172, hMLH1) (FITC)
Sign In for Pricing
View Details MBS6426807-02 5x 0.1 mL
MLH1 (Human Mul L Homologue, Familial Nonpolyposis Colin Cancer Type 2, COCA2, Colon Cancer Type 2, COCA2, FCC2, HNPCC, HNPCC2, MGC5172, hMLH1) (FITC)
Sign In for Pricing
View Details 
MBS7098717 Inquire
Recombinant Bacillus halodurans Protoheme IX farnesyltransferase (ctaB), partial
Sign In for Pricing
View Details